跳至主要内容
临床试验/NCT05069311
NCT05069311已完成不适用

Effects of Multimodal Analgesia on Monocyte Chemoattractant Protein-1, Brain-derived Neurotrophic Factor, and RNA-124 Micro to Acute Pain in Patients Who Underwent Hysterectomy

Udayana University1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2021年10月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
62
试验地点
1
主要终点
Preoperative MiRNA-124

研究概览

简要总结

The inflammatory process is the main mechanism in the occurrence of acute postoperative pain. It is also the main risk for the development of acute pain into persistent pain. Inflammation occurs in the process of peripheral sensitization and central sensitization with various inflammatory mediators. Postoperatively, there will be proliferation and activation of microglia and astrocytes which will then activate inflammatory receptors and signaling cascades of neurotransmitters, cytokines, and chemokines. There has been a lot of clinical research evidence that multimodal analgesia can adequately treat acute pain and can prevent the development of acute postoperative pain into persistent pain and chronic postoperative pain, but the molecular mechanisms are not fully understood.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Scheduled for elective hysterectomy
  • American Society of Anesthesiologists (ASA) physical status 1 to 3

排除标准

  • allergy to studied drugs
  • history of chronic pain
  • history of hepatitis, depression, peptic ulcer, or acute myocardial infarction
  • receive intraoperative massive blood transfusion
  • prolonged coagulation
  • body mass index >35 kg/m2
  • patients with neurological deficits
  • taking anti-platelet medications

研究组 & 干预措施

Hysterectomy

Experimental

Patients who undergo surgical hysterectomy that fits inclusion and exclusion criteria

干预措施: Multimodal analgesia (Drug)

Hysterectomy

Experimental

Patients who undergo surgical hysterectomy that fits inclusion and exclusion criteria

干预措施: Conventional intravenous analgesia (Drug)

结局指标

主要结局

Preoperative MiRNA-124

时间窗: 1-hour before surgery

serum level of MiRNA-124

Preoperative MCP-1

时间窗: 1-hour before surgery

serum level of MCP-1

Preoperative BDNF

时间窗: 1-hour before surgery

serum level of BDNF

Postoperative MCP-1

时间窗: 48-hours after surgery

serum level of MCP-1

Postoperative BDNF

时间窗: 48-hours after surgery

serum level of BDNF

Postoperative MiRNA-124

时间窗: 48-hours after surgery

serum level of MiRNA-124

次要结局

未报告次要终点

研究者

发起方
Udayana University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Ryalino, MD

Principal Investigator

Udayana University

研究点 (1)

Loading locations...

相似试验